PEN Q4 2019 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$145M+20.3% YoY

Gross Profit

$98M67.6% margin

Operating Income

$11M7.3% margin

Net Income

$10M6.7% margin

EPS (Diluted)

$0.27

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

-$3M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$666M

Total Liabilities

$180M

Stockholders' Equity

$486M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$145M	$121M	+20.3%
Gross Profit	$98M	$79M	+24.7%
Operating Income	$11M	$7M	+58.6%
Net Income	$10M	$7M	+45.5%

Revenue Segments

Neuro

$85M59%

Peripheral Vascular

$60M41%

Geographic Segments

UNITED STATES

$96M66%

Other Non-US

$40M27%

JAPAN

$10M7%